Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: 1-(3-Chlorophenyl)piperazine hydrochloride
RN: 13078-15-4
UNII: 7IM2GS7ILV
InChIKey: MHXPYWFZULXYHT-UHFFFAOYSA-N

Classification Code

  • Human Data

Molecular Formula

  • C10-H13-Cl-N2.Cl-H

Molecular Weight

  • 233.141
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • 1-(3-Chlorophenyl)piperazine hydrochloride

Synonyms

  • 1-(3-Chlorophenyl)piperazine hydrochloride
  • 1-(3-Chlorophenyl)piperazine monohydrochloride
  • 1-(m-Chlorophenyl)piperazine hydrochloride
  • EINECS 235-976-9
  • Piperazine, 1-(m-chlorophenyl)-, monohydrochloride
  • UNII-7IM2GS7ILV

Systematic Names

  • 1-(3-Chlorophenyl)piperazinium chloride
  • Piperazine, 1-(3-chlorophenyl)-, monohydrochloride

Registry Numbers

CAS Registry Number

  • 13078-15-4

FDA UNII

  • 7IM2GS7ILV

Related Registry Number

  • 6640-24-0 (Parent)

System Generated Number

  • 0013078154

Molecular Formulas

Molecular Formula

  • C10-H13-Cl-N2.Cl-H

Molecular Formula Fragments

  • C10-H13-Cl-N2
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C10H13ClN2.ClH/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13;/h1-3,8,12H,4-7H2;1H

InChIKey

MHXPYWFZULXYHT-UHFFFAOYSA-N

Smiles

c1(N2CCNCC2)cc(ccc1)Cl.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
rat LD50 intravenous 36mg/kg (36mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: PLEURAL THICKENING

BEHAVIORAL: TREMOR
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 17(Suppl,
rat LD50 oral 142mg/kg (142mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 17(Suppl,
women TDLo oral 500ug/kg (0.5mg/kg) BEHAVIORAL: HEADACHE

GASTROINTESTINAL: NAUSEA OR VOMITING
Clinical Pharmacology and Therapeutics Vol. 43, Pg. 605, 1988.